← Evidence map

ArticleNeurodegenerative disease management2026

Real-world experience of ozanimod in adults with multiple sclerosis.

Jessica Cooperrider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41612670